Open Access
Endocrine properties and mechanism of action of oral contraceptives.
Saunders Fj
- Vol. 29, Iss: 3, pp 1211-1219
Reads0
Chats0
TLDR
The clinical effect of oral contraceptive seems to be to inhibit the release of "releasing factors" from the hypothalamus, which keeps production of follicle stimulating hormone and luteinizing hormone to a minimum which in turn prevents ovulation.Abstract:
The biological properties that may account for the effectiveness of oral contraceptives are progestational activity estogenicity and hormonal activity. The primary effect of most oral contraceptives is the inhibition of ovulation. The clinical effect of oral contraceptive seems to be to inhibit the release of "releasing factors" from the hypothalamus. This keeps production of follicle stimulating hormone (FSH) and luteinizing hormone (LH) to a minimum which in turn prevents ovulation. The presence of the exogenous hormones maintains the uterus and other target organs and thus simulates a cycle.read more
Citations
More filters
Book ChapterDOI
CHAPTER 1 – Mechanisms, Instrumentation, Recording Techniques, and Quantification of Responses
P.H. Venables,M.J. Christie +1 more
Journal ArticleDOI
Effects of various progestational preparations on gonadotropin secretion in ovariectomized immature female rats.
TL;DR: It is concluded that native progesterone cannot significantly lower gonadotropin levels in the absence of estrogens.
Journal ArticleDOI
Effects of contraceptive pills and intrauterine devices on urinary bladder
Mohamed M. Zahran,Mohamed I. Osman,Mostafa H. Kamel,M. M. Fayad,Hashem Mooro,Abdel Fattah Youssef +5 more
TL;DR: The incidence of bacteriuria and cystoscopic changes in women on oral contraceptives or users of IUD (intrauterine devices) were evaluated compared with a control group and the mode of action of ovarian hormones and their possible side effects on the bladder are discussed.
Journal ArticleDOI
Central and peripheral parameters of the menstrual cycle under the influence of a new combined oral contraceptive
J. Spona,W. H. F. Schneider +1 more
TL;DR: Evidence is provided that Neovletta® provides a very high degree of contraceptive protection even in the first treatment cycle after a switch‐over from a higher dosed pill, since it contains a back‐up mechanism in the case of a breakthrough ovulation.
Journal ArticleDOI
Action of an estradiol-17β antagonist in intact, ovariectomized, hypophysectomized and hypophysectomized-ovariectomized rats
TL;DR: Estradiol-17β and/or CN-55, 945-27 induced uterine weight increase differs in intact and in operated animals, and the lack of activity in intact animals does not appear to be solely dependent upon the uterine response to estradiol- 17β.